Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy
Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy
Enrolling by invitation · NCT06664541 · Registry updated 2024-10-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Enrolling by invitation | Not stated | 2024-10-29 | NCT06664541 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Georgetown University | 73 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Georgetown University Medical Center | Washington D.C. | United States | 62 |